These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 228888)

  • 1. The role of cellular immunity in the infection with herpes simplex virus.
    Kirchner H; Schröder CH; Zawatzky R; Kleinicke C
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):149-58. PubMed ID: 228888
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes simplex virus immunology: problems, progress, and promises.
    Kohl S
    J Infect Dis; 1985 Sep; 152(3):435-40. PubMed ID: 2993439
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains.
    Armerding D; Rossiter H
    Immunobiology; 1981; 158(4):369-79. PubMed ID: 6263793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD; Bell RB; Aurelian L
    Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.
    Irie H; Harada Y; Kataoka M; Nagamuta M; Moriya Y; Handa M; Saito M; Matsubara S; Kojima K; Sugawara Y
    J Virol; 1992 Apr; 66(4):2428-34. PubMed ID: 1312638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of recurrent infection by Herpesvirus hominis.
    Bierman SM
    Arch Dermatol; 1976 Oct; 112(10):1459-61. PubMed ID: 183607
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 9. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication.
    Sarmiento M
    J Immunol; 1988 Oct; 141(8):2740-8. PubMed ID: 2844905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of host-cell herpes-simplex virus interactions(s) that renders cells susceptible to virus-specific cytotoxic T cells.
    Sethi KK; Wolff MH
    Immunobiology; 1980 Dec; 157(4-5):365-78. PubMed ID: 6256287
    [No Abstract]   [Full Text] [Related]  

  • 12. Herpes simplex virus vaccines.
    Wise TG; Pavan PR; Ennis FA
    J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus.
    Simmons A; Nash AA
    J Infect Dis; 1987 Apr; 155(4):649-54. PubMed ID: 3029240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
    Russell AS; Kaiser JT
    J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interferon-gamma in immunity to herpes simplex virus.
    Yu Z; Manickan E; Rouse BT
    J Leukoc Biol; 1996 Oct; 60(4):528-32. PubMed ID: 8864138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection.
    Armerding D; Scriba M; Hren A; Rossiter H
    Antiviral Res; 1982 May; 2(1-2):3-11. PubMed ID: 6980627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.